» Articles » PMID: 32277901

Outpatient Management of Alcohol-related Liver Disease

Overview
Specialty Gastroenterology
Date 2020 Apr 12
PMID 32277901
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Alcohol-related liver disease has become the leading indication for liver transplantation in the USA, partly due to an increase in the prevalence of high-risk drinking behaviour and alcohol use disorder, particularly among young women. Achieving sustained alcohol abstinence might not only prevent the development and progression of alcohol-related liver disease, but could also lead to clinically significant improvements, even in the advanced stages of disease. In this Series paper, we discuss the diagnosis and outpatient management of alcohol-related liver disease, with an emphasis on treatment options for alcohol use disorder and the assessment of nutritional status.

Citing Articles

Current and emerging therapies for alcohol-associated hepatitis.

Idalsoaga F, Ayares G, Diaz L, Arnold J, Ayala-Valverde M, Hudson D Liver Res. 2025; 7(1):35-46.

PMID: 39959695 PMC: 11792060. DOI: 10.1016/j.livres.2023.03.002.


Aetiology of chronic liver disease is a valuable factor for stratifying adverse outcomes of acute decompensation: prospective observational study.

Kim J, Kim S, Song D, Kim H, Yoon E, Park J Ann Med. 2025; 57(1):2428431.

PMID: 39856091 PMC: 11770857. DOI: 10.1080/07853890.2024.2428431.


Treatment of Alcohol Use Disorder: Behavioral and Pharmacologic Therapies.

Tareen K, Clifton E, Perumalswami P, Mellinger J, Winder G Clin Liver Dis. 2024; 28(4):761-778.

PMID: 39362720 PMC: 11450263. DOI: 10.1016/j.cld.2024.06.011.


Human Neutrophil Alpha-Defensins Promote NETosis and Liver Injury in Alcohol-Related Liver Cirrhosis: Potential Therapeutic Agents.

Rycyk-Bojarzynska A, Kasztelan-Szczerbinska B, Cichoz-Lach H, Surdacka A, Rolinski J J Clin Med. 2024; 13(5).

PMID: 38592082 PMC: 10931661. DOI: 10.3390/jcm13051237.


Treatment of alcohol use disorder in patients with alcohol-associated liver disease: Innovative approaches and a call to action.

Haque L, Zuluaga P, Muga R, Fuster D Addict Sci Clin Pract. 2024; 19(1):19.

PMID: 38504384 PMC: 10949674. DOI: 10.1186/s13722-024-00448-8.


References
1.
Tandon P, Low G, Mourtzakis M, Zenith L, Myers R, Abraldes J . A Model to Identify Sarcopenia in Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2016; 14(10):1473-1480.e3. DOI: 10.1016/j.cgh.2016.04.040. View

2.
Vancampfort D, Hallgren M, Mugisha J, De Hert M, Probst M, Monsieur D . The Prevalence of Metabolic Syndrome in Alcohol Use Disorders: A Systematic Review and Meta-analysis. Alcohol Alcohol. 2016; 51(5):515-21. DOI: 10.1093/alcalc/agw040. View

3.
Mellinger J, Shedden K, Winder G, Tapper E, Adams M, Fontana R . The high burden of alcoholic cirrhosis in privately insured persons in the United States. Hepatology. 2018; 68(3):872-882. DOI: 10.1002/hep.29887. View

4.
Schomerus G, Lucht M, Holzinger A, Matschinger H, Carta M, Angermeyer M . The stigma of alcohol dependence compared with other mental disorders: a review of population studies. Alcohol Alcohol. 2010; 46(2):105-12. DOI: 10.1093/alcalc/agq089. View

5.
Shen Y, Chang Y, Fang C, Lin Y . Zinc supplementation in patients with cirrhosis and hepatic encephalopathy: a systematic review and meta-analysis. Nutr J. 2019; 18(1):34. PMC: 6612144. DOI: 10.1186/s12937-019-0461-3. View